Cargando…
Paradoxical Arthralgia Secondary to Anti-Tumor-Necrosis-Factor Alpha Therapy in Crohn’s Disease
The current treatment of choice for polyarthralgia in Crohn’s disease consists of disease-modifying agents and anti-inflammatory therapy, such as anti-tumor-necrosis-factor alpha inhibitors like infliximab. However, here we report the case of a patient with longstanding Crohn’s disease, who develope...
Autores principales: | Thurlapati, Aswani, Gandu, Siva Santosh Kumar, Kulkarni, Shreedhar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301290/ https://www.ncbi.nlm.nih.gov/pubmed/34327073 http://dx.doi.org/10.7759/cureus.15835 |
Ejemplares similares
-
The Efficacy of Anti-Tumor Necrosis Factor Alpha for Symptomatic Stricturing Small Bowel Crohn’s Disease
por: Alourfi, Mansour, et al.
Publicado: (2020) -
Myosin Heavy Chain 9 (MYH9)-Related Congenital Macrothrombocytopenia
por: Thurlapati, Aswani, et al.
Publicado: (2021) -
Celiac Disease Masquerading as Arthralgia
por: Priyadarshini, Shista, et al.
Publicado: (2022) -
Tumor Necrosis Factor Alpha Blockade and Multiple Sclerosis: Exploring New Avenues
por: Zahid, Maryam, et al.
Publicado: (2021) -
A 14-Year-Old Female With Several-Week History of Rash, Worsening Diffuse Arthralgias, and Fevers
por: Deskins, Seth J, et al.
Publicado: (2022)